<DOC>
	<DOCNO>NCT01443338</DOCNO>
	<brief_summary>The purpose study determine whether Triptergium wilfordii , Acitretin effective safe treatment patient moderate severe psoriasis vulgaris .</brief_summary>
	<brief_title>Study Evaluating Efficacy Safety Triptergium Wilfordii Acitretin Psoriasis Vulgaris - CHINA201002016-2</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Acitretin</mesh_term>
	<criteria>Adults sex , age 18 75 year . Have diagnosis psoriasis vulgaris , PASI score 7 great . Capable give informed consent consent must obtain prior study related procedure . Currently erythrodermic , guttate pustular psoriasis . Have active dermatosis may affect disease assessment psoriasis . Have use investigational drug , biologic systemic immunosuppressant within previous 1 month.. Have use topical medications/treatments could affect psoriasis PASI evaluation ( eg , corticosteroid , tar , phototherapy et al . ) within 2 week . Have acute chronic recurrent infectious disease , difficult control . Have history HBV HCV infection , HIV antibody test positive . AST , ALT blood fat level must within 1.5 time ULN range laboratory conduct test . Are pregnant , nursing , plan pregnancy come two year ( men woman ) enrol study . Have severe systemic disease history malignancy . Have show previous hypersensitivity Triptergium wilfordii Acitretin . Have condition suitable join trial , judge investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Triptergium wilfordii</keyword>
	<keyword>Acitretin</keyword>
	<keyword>psoriasis vulgaris</keyword>
</DOC>